Drug Profile


Alternative Names: EK 49; Jia-Wei-Gui-Pi-Tang

Latest Information Update: 17 Nov 2003

Price : $50

At a glance

  • Originator Nippon Organon
  • Class Antidementias; Herbal medicines; Neuroprotectants; Traditional-Chinese-medicine
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Alzheimer's disease; Anxiety disorders; Major depressive disorder; Menopausal syndrome; Neurological disorders

Most Recent Events

  • 17 Nov 2003 Discontinued - Clinical-Phase-Unknown for Anxiety disorders in Japan (unspecified route)
  • 17 Nov 2003 Discontinued - Preclinical for Alzheimer's disease in Japan (unspecified route)
  • 17 Nov 2003 Discontinued - Preclinical for Depression in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top